Is it possible to predict the pCR with CBC? A commentary on “correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer” by Meng et al.
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-06-01
|
| Series: | Translational Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523322000651 |
| _version_ | 1828766190835597312 |
|---|---|
| author | Eda Tanrıkulu Şimşek Batuhan Bayram Alev Yıldırım Ahmet Emre Eşkazan |
| author_facet | Eda Tanrıkulu Şimşek Batuhan Bayram Alev Yıldırım Ahmet Emre Eşkazan |
| author_sort | Eda Tanrıkulu Şimşek |
| collection | DOAJ |
| first_indexed | 2024-12-11T07:00:59Z |
| format | Article |
| id | doaj.art-4086c0f00b0647a18eeb2aede7ab4485 |
| institution | Directory Open Access Journal |
| issn | 1936-5233 |
| language | English |
| last_indexed | 2024-12-11T07:00:59Z |
| publishDate | 2022-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Translational Oncology |
| spelling | doaj.art-4086c0f00b0647a18eeb2aede7ab44852022-12-22T01:16:36ZengElsevierTranslational Oncology1936-52332022-06-0120101403Is it possible to predict the pCR with CBC? A commentary on “correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer” by Meng et al.Eda Tanrıkulu Şimşek0Batuhan Bayram1Alev Yıldırım2Ahmet Emre Eşkazan3Department of Medical Oncology, Anadolu Medical Center, Kocaeli, TurkeyCerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, TurkeyCerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, TurkeyDivision of Hematology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Fatih, Turkey; Corresponding author.http://www.sciencedirect.com/science/article/pii/S1936523322000651Breast cancerHER-2 Proto-oncogene proteinLymphocytesMonocytesNeoadjuvant treatment |
| spellingShingle | Eda Tanrıkulu Şimşek Batuhan Bayram Alev Yıldırım Ahmet Emre Eşkazan Is it possible to predict the pCR with CBC? A commentary on “correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer” by Meng et al. Translational Oncology Breast cancer HER-2 Proto-oncogene protein Lymphocytes Monocytes Neoadjuvant treatment |
| title | Is it possible to predict the pCR with CBC? A commentary on “correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer” by Meng et al. |
| title_full | Is it possible to predict the pCR with CBC? A commentary on “correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer” by Meng et al. |
| title_fullStr | Is it possible to predict the pCR with CBC? A commentary on “correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer” by Meng et al. |
| title_full_unstemmed | Is it possible to predict the pCR with CBC? A commentary on “correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer” by Meng et al. |
| title_short | Is it possible to predict the pCR with CBC? A commentary on “correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer” by Meng et al. |
| title_sort | is it possible to predict the pcr with cbc a commentary on correlation analysis of lymphocyte monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer by meng et al |
| topic | Breast cancer HER-2 Proto-oncogene protein Lymphocytes Monocytes Neoadjuvant treatment |
| url | http://www.sciencedirect.com/science/article/pii/S1936523322000651 |
| work_keys_str_mv | AT edatanrıkulusimsek isitpossibletopredictthepcrwithcbcacommentaryoncorrelationanalysisoflymphocytemonocyteratiowithpathologicalcompleteresponseandclinicalprognosisofneoadjuvantchemotherapyinpatientswithbreastcancerbymengetal AT batuhanbayram isitpossibletopredictthepcrwithcbcacommentaryoncorrelationanalysisoflymphocytemonocyteratiowithpathologicalcompleteresponseandclinicalprognosisofneoadjuvantchemotherapyinpatientswithbreastcancerbymengetal AT alevyıldırım isitpossibletopredictthepcrwithcbcacommentaryoncorrelationanalysisoflymphocytemonocyteratiowithpathologicalcompleteresponseandclinicalprognosisofneoadjuvantchemotherapyinpatientswithbreastcancerbymengetal AT ahmetemreeskazan isitpossibletopredictthepcrwithcbcacommentaryoncorrelationanalysisoflymphocytemonocyteratiowithpathologicalcompleteresponseandclinicalprognosisofneoadjuvantchemotherapyinpatientswithbreastcancerbymengetal |